Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2024-11-21

FDA Approved: SULINDAC — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental labeling change for sulindac from Actavis Pharma, updating the product labeling under the ANDA. This reflects adjustments to the mar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulindac (sulindac)

Snippet

SUPPL AP for SULINDAC (SULINDAC)